CSVYX
Price
$60.61
Change
-$0.10 (-0.16%)
Updated
Jul 31 closing price
Net Assets
2.5B
VSCAX
Price
$31.11
Change
+$0.33 (+1.07%)
Updated
Jul 31 closing price
Net Assets
11.11B
Interact to see
Advertisement

CSVYX vs VSCAX

CSVYX vs VSCAX Comparison Chart in %
View a ticker or compare two or three
VS
CSVYX vs. VSCAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSVYX is a Buy and VSCAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCAX has more cash in the bank: 11.1B vs. CSVYX (2.5B). CSVYX pays higher dividends than VSCAX: CSVYX (1.39) vs VSCAX (0.21). CSVYX was incepted earlier than VSCAX: CSVYX (17 years) vs VSCAX (27 years). VSCAX (1.10) is less costly to investors than CSVYX (0.84). VSCAX is a more actively managed with annual turnover of: 79.00 vs. CSVYX (72.00). VSCAX has a lower initial minimum investment than CSVYX: VSCAX (1000) vs CSVYX (1000000). VSCAX annual gain was more profitable for investors over the last year : 29.96 vs. CSVYX (22.79). VSCAX return over 5 years is better than : 56.23 vs. CSVYX (19.43).
CSVYXVSCAXCSVYX / VSCAX
Total Expense Ratio0.811.1074%
Annual Report Gross Expense Ratio0.841.1076%
Fund Existence17 years27 years-
Gain YTD14.44522.91663%
Front LoadN/A6%-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.5B11.1B22%
Annual Yield % from dividends1.390.21668%
Returns for 1 year22.7929.9676%
Returns for 3 years25.3858.1844%
Returns for 5 years19.4356.2335%
Returns for 10 years64.5197.8466%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
OCTP32.560.13
+0.41%
PGIM S&P 500 Buffer 12 ETF - Oct
FTPA8.56-0.01
-0.10%
Franklin Pennsylvania Municipal Inc ETF
AGZ108.44-0.13
-0.12%
iShares Agency Bond ETF
JBND52.68-0.11
-0.21%
JPMorgan Active Bond ETF
MRNY14.40-0.62
-4.13%
YieldMax MRNA Option Income Strategy ETF